Exagen, Inc. (XGN)
8.47
+0.30
(+3.67%)
USD |
NASDAQ |
Oct 05, 16:00
8.47
0.00 (0.00%)
After-Hours: 16:30
Exagen Market Cap : 204.92M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 197.66M |
| October 01, 2026 | 190.88M |
| September 30, 2026 | 196.69M |
| September 29, 2026 | 200.80M |
| September 28, 2026 | 205.16M |
| September 25, 2026 | 210.96M |
| September 24, 2026 | 211.45M |
| September 23, 2026 | 206.85M |
| September 22, 2026 | 211.45M |
| September 21, 2026 | 208.54M |
| September 18, 2026 | 203.46M |
| September 17, 2026 | 190.40M |
| September 16, 2026 | 188.22M |
| September 15, 2026 | 181.21M |
| September 14, 2026 | 177.82M |
| September 11, 2026 | 170.08M |
| September 10, 2026 | 168.63M |
| September 09, 2026 | 176.85M |
| September 08, 2026 | 176.61M |
| September 04, 2026 | 183.38M |
| September 03, 2026 | 182.42M |
| September 02, 2026 | 181.69M |
| September 01, 2026 | 172.25M |
| August 31, 2026 | 177.58M |
| August 28, 2026 | 178.79M |
| Date | Value |
|---|---|
| August 27, 2026 | 181.93M |
| August 26, 2026 | 185.56M |
| August 25, 2026 | 183.87M |
| August 24, 2026 | 185.08M |
| August 21, 2026 | 191.61M |
| August 20, 2026 | 188.22M |
| August 19, 2026 | 179.75M |
| August 18, 2026 | 159.43M |
| August 17, 2026 | 162.09M |
| August 14, 2026 | 161.13M |
| August 13, 2026 | 159.19M |
| August 12, 2026 | 159.43M |
| August 11, 2026 | 163.79M |
| August 10, 2026 | 160.64M |
| August 07, 2026 | 166.21M |
| August 06, 2026 | 159.43M |
| August 05, 2026 | 160.19M |
| August 04, 2026 | 155.37M |
| August 03, 2026 | 112.73M |
| July 31, 2026 | 109.12M |
| July 30, 2026 | 112.49M |
| July 29, 2026 | 104.78M |
| July 28, 2026 | 107.19M |
| July 27, 2026 | 105.99M |
| July 24, 2026 | 112.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Myriad Genetics, Inc. | 437.37M |
| BioRestorative Therapies, Inc. | 2.815M |
| CareDx, Inc. | 3.593B |
| Natera, Inc. | 61.10B |
| Sera Prognostics, Inc. | 79.66M |
Market Cap Related Metrics
| PS Ratio | 2.815 |
| Price to Book Value | 16.77 |
| Price | 8.47 |
| Earnings Yield | -9.51% |